prostate cancer Archives - Page 45 of 48 - Sperling Prostate Center

Great News About Multiparametric MRI

It is always gratifying for a doctor when something he or she wholeheartedly believes in gets affirmed by published research. For me, this is the case with a new Italian study, “The Roles of Multiparametric MRI, PCA3, and PHI: Which Is The Best Predictor of Prostate Cancer After a Negative Biopsy?”[i] The authors recognize the keep reading

Don’t Be the Victim of Prostate Cops

When you’re cruising along in good health, it’s easy to take that smooth road for granted. An annual physical with a PSA is a little like stopping at a red light and waiting till the light changes. When the physical ends, you figure it’s a green light and leave the office, expecting to go on keep reading

Exercise Related to Treatment Success

A study presented in 2014 at the AACR-Prostate Cancer Foundation Conference on Advances in Prostate Cancer Research reported a surprising relationship between vigorous exercise and the shape of blood vessels found in prostate cancer tumors. Men who walked faster prior to a diagnosis of prostate cancer were found to have more regularly shaped blood vessels keep reading

Prostate Cancer and Medicare Fraud

It’s tempting to become cynical about medicine when one hears reports of Medicare abuse or violations of Federal laws. These stories are especially rankling when greed appears to be the motive, and the victims are cancer patients. patients. Thankfully, our Sperling Prostate Center has never been party to Medicare fraud or legal action related to keep reading

Want to Prevent Lethal Prostate Cancer? Know The Score

I have previously written several blogs about the correlation between lifestyle choices (diet, exercise, supplements, etc.) and the risk of prostate cancer (PCa). There is ample evidence that healthy choices can reduce risk by helping the genes that discourage tumor growth. On the other side, there are also plenty of studies that show a connection keep reading

New Image-Based Analysis Predicts Focal Laser Ablation Outcomes

I’m excited to announce news about a new way to quantify the effects of focal laser ablation (FLA) in a way that may allow us to predict long term treatment success. I was a member of a research team out of Case Western Reserve University that developed an innovative way to use MRI before, during keep reading

An Update on the Current Role for Prostate Multiparametric MRI

A prominent urologist wrote an articulate article on how the U.S. Preventive Services Task Force made a recommendation against broad PSA screening based on an oversimplification of a complex issue. He made an eloquent declaration on several ways in which urologists are “embracing strategies to preserve, or even further decrease, prostate cancer mortality while minimizing keep reading

Multiparametric MRI Adds Value to Surveillance Monitoring

It’s always reassuring to receive affirmation, especially when offering a leading edge medical program to prostate cancer patients. Such was the case for us at the Sperling Prostate Center with the December, 2015 publication of a UCLA Medical Center study on the value-added of multiparametric MRI during Active Surveillance (AS). The authoritative Journal of Urology keep reading

Concern Regarding Radiation Overuse

Here’s a little quiz: Which whole gland therapy for prostate cancer has the highest risk of recurrence? Radical prostatectomy Radiation therapy Cryotherapy of the whole gland HIFU of the whole gland If you answered radiation, you are correct. According to a recent article, the rate of prostate cancer coming back after conventional external beam radiation keep reading

The Right Way to do Active Surveillance

We know that the use of Active Surveillance (AS) as a way to hold off on prostate cancer (PCa) treatment is on the rise. Concerns about overtreatment, such as doing a prostatectomy on a patient who only has a small Gleason 3+3 tumor, stem from two recognized realities: Insignificant PCa may be slow-growing (indolent) and keep reading

Tag: prostate cancer